AB Science S.A. (AB.PA)
Develops experimental drugs targeting nerve, immune, and cancer diseases, with a lead candidate in late-stage trials.
0.57-0.18%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-60.2%
The outlook
AB Science trades near its 52-week low and well below its key moving averages, showing weak short-term momentum. Analyst coverage is sparse overall, though the average price target sits significantly above the current price. The StockGlow score leans bearish at 21/100, reflecting the stock's depressed technicals despite the elevated target.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range6% of the way from its 52-week low to high
Price targetAvg target +688% vs current price
Market cap
$41.7M
52-wk high
1.73
52-wk low
0.50
50-day avg
0.82
200-day avg
1.13
Trailing P/E
—